June 2014

Features

These thought-provoking abstracts from ARVO will likely help define best practices in the near future.

High-tech tools may improve contact lens manufacturing efficiency—and patient vision and comfort.

Don't be caught off guard by this rare complication of contact lens wear.

Collagen crosslinking offers clinicians the potential to forever alter the impact of keratoconus on our patients.

A number of barriers can prevent presbyopes from experiencing comfortable lens wear. Fortunately, some new lens options may be able to change that.

The FDA has completely revised its contact lens solution testing—a dramatic step forward in ensuring patient safety.

Novel drug delivery methods were on display at this year's annual ARVO meeting.

Older individuals with high endothelial cell counts may be the best donors for DMEK.

Here is a snapshot of what is happening in the industry.

A new eye drop may help your presbyopes.

Taking advantage of this new policy may provide much-needed growth for the contact lens industry—and your bottom line.

This modality can be used to treat a number of corneal conditions—including many you might not expect.